{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/198-US10,603,412(active).pdf"}, "page_content": "TABLE 11\n\ndissolving the biodegradable polymer in an organic sol- vent to form a solution;\n\nhm Metallic material 45 hm Magnesium beads (5 g) Pre-treatment sore. 24 hrs Temperature Duration Silane Treatment Silane coupling agent 3-Aminoproyltrimethylsilane (Weight of Mg/Volume of ASCA: 2 g/ml) Solvent Cyclohexane (250 ml) Catalyst Tricthylamine (0.75 ml) \u2018Treatment Temperature 80\u00b0C. \u2018Treatment Time 3 hrs Post Heat Treatment \u2018Temperature 80\u00b0 C Duration 5 his Pressure 100 mBar Hybrid fabrication Amount of Mg beads added Amount of PCL added Method of fabrication O.1 g5 0.4 g: 0.6 g3 0.8 \u00a2 1g Thermal formation method 40 45 50\n\nadding the biodegradable metallic material, after the sur- face treatment process has been performed, to the solution;\n\nsonicating the solution;\n\ndrying the solution to obtain a pre-hybrid material;\n\nperforming a heat treatment process on the pre-hybrid material; and\n\nperforming a coupling agent treatment on the surface- treated biodegradable metallic material before adding the biodegradable metallic material to the solution;\n\nwherein performing the coupling agent treatment com- prises:\n\nadding the silane coupling agent and a catalyst to second solvent to form a coupling agent solution;\n\nadding the biodegradable metallic material to the cou- pling agent solution to form a coupling agent solu- tion mixture;\n\nheating the coupling agent solution reflux with nitrogen; and mixture under\n\nheat-treating the surface-treated biodegradable metallic material in a low-vacuum oven, and\n\n60\n\nCompression testing was performed to measure strength of hybrid materials of the subject invention.\n\nwherein the biodegradable polymer is a copolymer e-caprolactone (e-CL) and y-butyrolactone (y-BL), $-valerolactone (8-VL), y-valerolactone (y-VL), y-caprolactone (y-CL), or any combination thereof.", "type": "Document"}}